BioNTech Sees Higher Dose Capacity; Brazil Deaths: Virus Update

We're tracking the latest on the coronavirus outbreak and the global response. Sign up here for our daily newsletter on what you need to know.

BioNTech SE may be able to produce 3 billion doses of the Covid-19 vaccine with its partner Pfizer Inc. next year. The companies’ vaccine has shown a high ability in lab experiments to neutralize strains first detected in Brazil, the U.K. and South Africa. New York state lowered its vaccine eligibility age to 60 from 65.